Excipients in the paediatric population: A review

K Rouaz, B Chiclana-Rodríguez, A Nardi-Ricart… - Pharmaceutics, 2021 - mdpi.com
… study seeks to critically review the use of excipients in the paediatric population. This study
… On the one hand, this review describes the most frequent excipients used in paediatric

The current states, challenges, ongoing efforts, and future perspectives of pharmaceutical excipients in pediatric patients in each country and region

J Saito, A Agrawal, V Patravale, A Pandya, S Orubu… - Children, 2022 - mdpi.com
… For example, in Africa, we only reviewed the current situation on pharmaceutical excipients
regulation in 2 out of 54 African countries. The same applies to the other regions. Further …

[PDF][PDF] Excipients in the paediatric population: a review. Pharmaceutics 2021; 13: 387

K Rouaz, B Chiclana-Rodríguez, A Nardi-Ricart… - 2021 - pdfs.semanticscholar.org
… study seeks to critically review the use of excipients in the paediatric population. This study
… On the one hand, this review describes the most frequent excipients used in paediatric

Paediatric pharmacology: remember the excipients

V Fabiano, C Mameli, GV Zuccotti - Pharmacological research, 2011 - Elsevier
… However, this document was not intended as a paediatric regulatory guidance. … excipients;
however, in this document, no safety levels of excipients for the paediatric population have …

Safety and biopharmaceutical challenges of excipients in off-label pediatric formulations

A Belayneh, E Tadese, F Molla - International Journal of General …, 2020 - Taylor & Francis
… was to review the safety and biopharmaceutical challenges of commonly found excipients in
off-… as well as to show the current progress to alleviate pediatric toxicity related to excipients. …

Selecting appropriate excipients for paediatric dosage form− Paediatric excipients risk assessment (PERA) framework–Part 1

S Salunke, A Agrawal, J Walsh, A Nunn… - European Journal of …, 2024 - Elsevier
paediatric age range, acute versus chronic use, and clinical risk–benefit of the disease, active
and excipient… the suitability of excipients to the specific paediatric population. Indicative list …

[HTML][HTML] Paediatric specific dosage forms: Patient and formulation considerations

D Khan, D Kirby, S Bryson, M Shah… - International journal of …, 2022 - Elsevier
… Lastly, this review highlights factors affecting paediatric medicine adherence and … which
have shown to be problematic excipients within the paediatric population. Co-administrating with …

Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates

K Sridharan, HMSN Hasan, M Al Jufairi… - Expert Opinion on …, 2020 - Taylor & Francis
… Newborns are exposed to almost 60 different excipients used in medicines [Citation12].
Surprisingly, review of a hospital treatment’s guide in Spain revealed that nearly 25% of the …

From paediatric formulations development to access: Advances made and remaining challenges

C Litalien, S Bérubé, C Tuleu, A Gilpin… - British Journal of …, 2022 - Wiley Online Library
… This review focuses on the progress made over the last two decades with … , and that screening
and careful selection of excipients is a critical step in paediatric formulation development. …

Paediatric formulations in practice

C Tuleu, I Costello, PF Long, IK Wong… - Paediatric drug …, 2007 - books.google.com
… Dosing accuracy, reproducibility and bioavailability, due to a general lack of information
and peer-reviewed research in this field, are major problems. The suitability of excipients